Frances G. Bormel
View detailed information about Frances G. Bormel, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of Compounding Quality and Compliance.
Documents (5)
- UNTITLED LETTER · QuVa Pharma, Inc. · September 24, 2024
- WARNING LETTER · PQ Pharmacy LLC · April 4, 2025
- UNTITLED LETTER · Wells Pharmacy, Inc · April 14, 2025
- UNTITLED LETTER · Sincerus Florida, LLC dba SKNV · February 13, 2025
- UNTITLED LETTER · STAQ Pharma of Ohio, LLC · May 6, 2025
Related Office
Person Information
Name
Frances G. Bormel
Title
Director
Role
Regulatory Personnel
ID: 75a42bda-8a74-4dd2-a081-c7f1bf9cf417
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.